Rx Iverhart Max, Med 25-50lb, Single Chewable Tablet

Dosage

Toy : 6.0 to 12 lbs Ivermectin Content: 34 mcg
Pyrantel Pamoate Content: 28.5 mg
Praziquantel Content: 28.5 mg

Small : 12.1 to 25 Ivermectin Content: 68 mcg
Pyrantel Pamoate Content: 57 mg
Praziquantel Content: 57 mg

Medium : 25.1 to 50 Ivermectin Content: 136 mcg
Pyrantel Pamoate Content: 114 mg
Praziquantel Content: 114 mg

Large : 50.1 to 100 Ivermectin Content: 272 mcg
Pyrantel Pamoate Content: 228 mg
Praziquantel Content: 228 mg

Iverhart Max® Chewable Tablets are recommended for dogs 8 weeks of age and older. For dogs over 100 lbs, use the appropriate combination of these Chewable Tablets.

Directions

Remove only one tablet at a time from the foil-backed blister card. Return the remaining tablets to their box to protect the product from light. Iverhart Max® Chewable Tablets can be offered to the dog by hand or be added intact to a small amount of dog food. Care should be taken that the dog consumes the complete dose, and the dog should be observed for a few minutes after administration to ensure that part of the dose is not lost or rejected. If it is suspected that any of the dose has been lost, redosing is recommended.

Iverhart Max® Chewable Tablets should be given at monthly intervals during the period of the year when mosquitoes (vectors), potentially carrying infective heartworm larvae, are active. The initial dose must be given within a month (30 days) after the dog's first exposure to mosquitoes. The final dose must be given within a month (30 days) after the dog's last exposure to mosquitoes.

When replacing another heartworm preventive product in a heartworm disease prevention program, the first dose of Iverhart Max® Chewable Tablets must be given within a month (30 days) of the last dose of the former medication. A heartworm test should be performed prior to switching heartworm preventive products.

If the interval between doses exceeds a month (30 days), the efficacy of ivermectin can be reduced. Therefore, for optimal performance, the tablet must be given once a month on or about the same day of the month. If treatment is delayed, whether by a few days or many, immediate treatment with Iverhart Max® Chewable Tablets and resumption of the recommended dosing regimen will minimize the opportunity for the development of adult heartworms.

Cautions

For use in dogs only. Keep this and all drugs out of reach of children. In safety studies, testicular hypoplasia was observed in some dogs receiving 3 and 5 times the maximum recommended dose monthly for 6 months (see Animal Safety).

In case of ingestion by humans, clients should be advised to contact a physician immediately. Physicians may contact a Poison Control Center for advice concerning cases of ingestion by humans.

For a copy of the Material Safety Data Sheet (MSDS), or to report adverse reactions, call 1-800-338-3659.

Use with caution in sick, debilitated, or underweight animals and dogs weighing less than 10 lbs (see Animal Safety). The safe use of this drug has not been evaluated in pregnant or lactating bitches.

All dogs should be tested for existing heartworm infection before starting treatment with Iverhart Max® Chewable Tablets, which are not effective against adult D. immitis. Infected dogs should be treated to remove adult heartworms and microfilariae before initiating a heartworm prevention program.

While some microfilariae may be killed by the ivermectin in Iverhart Max® Chewable Tablets at the recommended dose level, Iverhart Max® Chewable Tablets are not effective for microfilariae clearance. A mild hypersensitivity-type reaction, presumably due to dead or dying microfilariae and particularly involving a transient diarrhea, has been observed in clinical trials with ivermectin alone after treatment of some dogs that have circulating microfilariae.

Adverse Reactions: Self-limiting adverse reactions including lethargy, limpness, salivation, shaking, diarrhea, decreased appetite, licking lips, and belching were reported between 20 minutes and 72 hours following treatment in a field study with Iverhart Max® Chewable Tablets. In clinical field trials with ivermectin/pyrantel pamoate, vomiting or diarrhea within 24 hours of dosing was rarely observed (1.1% of administered doses). The following adverse reactions have been reported following the use of ivermectin: depression/lethargy, vomiting, anorexia, diarrhea, mydriasis, ataxia, staggering, convulsions and hypersalivation.

Storage Information: Store at controlled room temperature of 59°-86°F (15°-30°C). Protect product from light.

How Supplied: Iverhart Max® Chewable Tablets are available in four dosage strengths (see dosage section) for dogs of different weights. Each strength comes in a box of 6 chewable tablets and in a box of 12 chewable tablets, packed 10 boxes per display box.

Prescription
This item requires a valid prescription from a licensed veterinarian.